1.
Ravasio R, Antonelli S, Rogai V, Fakhouri W, Capron JP, Losi S. Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy. Grhta [Internet]. 2018 Jul. 27 [cited 2024 Jun. 19];5(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/435